Skip to main content
Erschienen in: Surgical Endoscopy 2/2021

23.09.2020 | Dynamic Manuscript

Clinical outcomes of transanal total mesorectal excision using a lateral-first approach for low rectal cancer: a propensity score matching analysis

verfasst von: Takeru Matsuda, Kimihiro Yamashita, Hiroshi Hasegawa, Masataka Fujikawa, Hiroki Sakamoto, Masashi Yamamoto, Shingo Kanaji, Taro Oshikiri, Tetsu Nakamura, Satoshi Suzuki, Yoshihiro Kakeji

Erschienen in: Surgical Endoscopy | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Although transanal total mesorectal excision (ta-TME) is adopted for rectal cancer surgery by an increasing number of surgeons, it is still technically challenging. We have employed a lateral-first approach for ta-TME to overcome technical difficulties. However, its outcomes and advantage over conventional laparoscopic TME remain unclear.

Methods

Thirty-five consecutive patients who underwent ta-TME using a lateral-first approach (the ta-TME group) and 53 consecutive patients who underwent conventional laparoscopic TME (the lap-TME group) for low rectal cancer were included. Propensity score matching (PSM) was used to create balanced cohorts of ta-TME (n = 28) and lap-TME (n = 28). Their clinical outcomes were compared after PSM.

Results

The operative time and intraoperative blood loss were significantly lower in the ta-TME group than in the lap-TME group (P = 0.042 and P < 0.001, respectively). Postoperative complications ≥ Clavien–Dindo grade II were significantly less and postoperative hospital stay was significantly shorter in the ta-TME group (35.7% vs. 78.6%, P = 0.003, and 18 days vs. 32 days, P < 0.001, respectively). The distal margin was significantly larger in the ta-TME when excluding the abdominoperineal resection cases (20 mm vs. 10 mm, P = 0.032). The positive radial margin was observed in 2 of 28 patients (7.1%) in the ta-TME group.

Conclusions

Ta-TME using a lateral-first approach is feasible and may offer several advantages over lap-TME in terms of short-term outcomes. It might be an alternative safe approach for ta-TME. To confirm the oncological superiority of this surgery, further study in a larger population and for a longer follow-up period is warranted.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Matsuda T, Yamashita K, Hasegawa H, Oshikiri T, Hosono M, Higashino N, Yamamoto M, Matsuda Y, Kanaji S, Nakamura T, Suzuki S, Sumi Y, Kakeji Y (2018) Recent updates in the surgical treatment of colorectal cancer. Ann Gastroenterol Surg 2:129–136CrossRef Matsuda T, Yamashita K, Hasegawa H, Oshikiri T, Hosono M, Higashino N, Yamamoto M, Matsuda Y, Kanaji S, Nakamura T, Suzuki S, Sumi Y, Kakeji Y (2018) Recent updates in the surgical treatment of colorectal cancer. Ann Gastroenterol Surg 2:129–136CrossRef
2.
Zurück zum Zitat Fleshman J, Branda M, Sargent DJ, Boller AM, George V, Abbas M, Peters WR Jr, Maun D, Chang G, Herline A, Fichera A, Mutch M, Wexner S, Whiteford M, Marks J, Birnbaum E, Margolin D, Larson D, Marcello P, Posner M, Read T, Monson J, Wren SM, Pisters PW, Nelson H (2015) Effect of laparoscopic-assisted resection vs open resection of stage II or III rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial. JAMA 314:1346–1355CrossRef Fleshman J, Branda M, Sargent DJ, Boller AM, George V, Abbas M, Peters WR Jr, Maun D, Chang G, Herline A, Fichera A, Mutch M, Wexner S, Whiteford M, Marks J, Birnbaum E, Margolin D, Larson D, Marcello P, Posner M, Read T, Monson J, Wren SM, Pisters PW, Nelson H (2015) Effect of laparoscopic-assisted resection vs open resection of stage II or III rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial. JAMA 314:1346–1355CrossRef
3.
Zurück zum Zitat Fleshman J, Branda ME, Sargent DJ, Boller AM, George VV, Abbas MA, Peters WR Jr, Maun DC, Chang GJ, Herline A, Fichera A, Mutch MG, Wexner SD, Whiteford MH, Marks J, Birnbaum E, Margolin DA, Larson DW, Marcello PW, Posner MC, Read TE, Monson JRT, Wren SM, Pisters PWT, Nelson H (2019) Disease-free survival and local recurrence for laparoscopic resection compared with open resection of stage II to III rectal cancer: follow-up results of the ACOSOG Z6051 randomized controlled trial. Ann Surg 269:589–595CrossRef Fleshman J, Branda ME, Sargent DJ, Boller AM, George VV, Abbas MA, Peters WR Jr, Maun DC, Chang GJ, Herline A, Fichera A, Mutch MG, Wexner SD, Whiteford MH, Marks J, Birnbaum E, Margolin DA, Larson DW, Marcello PW, Posner MC, Read TE, Monson JRT, Wren SM, Pisters PWT, Nelson H (2019) Disease-free survival and local recurrence for laparoscopic resection compared with open resection of stage II to III rectal cancer: follow-up results of the ACOSOG Z6051 randomized controlled trial. Ann Surg 269:589–595CrossRef
4.
Zurück zum Zitat Stevenson AR, Solomon MJ, Lumley JW, Hewett P, Clouston AD, Gebski VJ, Davies L, Wilson K, Hague W, Simes J, Investigators AL (2015) Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial. JAMA 314:1356–1363CrossRef Stevenson AR, Solomon MJ, Lumley JW, Hewett P, Clouston AD, Gebski VJ, Davies L, Wilson K, Hague W, Simes J, Investigators AL (2015) Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial. JAMA 314:1356–1363CrossRef
5.
Zurück zum Zitat Sylla P, Rattner DW, Delgado S, Lacy AM (2010) NOTES transanal rectal cancer resection using transanal endoscopic microsurgery and laparoscopic assistance. Surg Endosc 24:1205–1210CrossRef Sylla P, Rattner DW, Delgado S, Lacy AM (2010) NOTES transanal rectal cancer resection using transanal endoscopic microsurgery and laparoscopic assistance. Surg Endosc 24:1205–1210CrossRef
6.
Zurück zum Zitat de Lacy AM, Rattner DW, Adelsdorfer C, Tasende MM, Fernandez M, Delgado S, Sylla P, Martinez-Palli G (2013) Transanal natural orifice transluminal endoscopic surgery (NOTES) rectal resection: "down-to-up" total mesorectal excision (TME)–short-term outcomes in the first 20 cases. Surg Endosc 27:3165–3172CrossRef de Lacy AM, Rattner DW, Adelsdorfer C, Tasende MM, Fernandez M, Delgado S, Sylla P, Martinez-Palli G (2013) Transanal natural orifice transluminal endoscopic surgery (NOTES) rectal resection: "down-to-up" total mesorectal excision (TME)–short-term outcomes in the first 20 cases. Surg Endosc 27:3165–3172CrossRef
7.
Zurück zum Zitat Deijen CL, Tsai A, Koedam TW, Veltcamp Helbach M, Sietses C, Lacy AM, Bonjer HJ, Tuynman JB (2016) Clinical outcomes and case volume effect of transanal total mesorectal excision for rectal cancer: a systematic review. Tech Coloproctol 20:811–824CrossRef Deijen CL, Tsai A, Koedam TW, Veltcamp Helbach M, Sietses C, Lacy AM, Bonjer HJ, Tuynman JB (2016) Clinical outcomes and case volume effect of transanal total mesorectal excision for rectal cancer: a systematic review. Tech Coloproctol 20:811–824CrossRef
8.
Zurück zum Zitat Lee L, Kelly J, Nassif GJ, deBeche-Adams TC, Albert MR, Monson JRT (2018) Defining the learning curve for transanal total mesorectal excision for rectal adenocarcinoma. Surg Endosc 34:1534CrossRef Lee L, Kelly J, Nassif GJ, deBeche-Adams TC, Albert MR, Monson JRT (2018) Defining the learning curve for transanal total mesorectal excision for rectal adenocarcinoma. Surg Endosc 34:1534CrossRef
9.
Zurück zum Zitat Courval V, Drolet S, Bouchard A, Bouchard P (2019) The role of transanal (Ta) dissection in the management of difficult primary and recurrent rectal cancer. BMJ Open Gastroenterol 6:e000305CrossRef Courval V, Drolet S, Bouchard A, Bouchard P (2019) The role of transanal (Ta) dissection in the management of difficult primary and recurrent rectal cancer. BMJ Open Gastroenterol 6:e000305CrossRef
10.
Zurück zum Zitat Penna M, Hompes R, Arnold S, Wynn G, Austin R, Warusavitarne J, Moran B, Hanna GB, Mortensen NJ, Tekkis PP, Ta TMERC (2017) Transanal total mesorectal excision: international registry results of the first 720 cases. Ann Surg 266:111–117CrossRef Penna M, Hompes R, Arnold S, Wynn G, Austin R, Warusavitarne J, Moran B, Hanna GB, Mortensen NJ, Tekkis PP, Ta TMERC (2017) Transanal total mesorectal excision: international registry results of the first 720 cases. Ann Surg 266:111–117CrossRef
11.
Zurück zum Zitat de Lacy FB, van Laarhoven J, Pena R, Arroyave MC, Bravo R, Cuatrecasas M, Lacy AM (2018) Transanal total mesorectal excision: pathological results of 186 patients with mid and low rectal cancer. Surg Endosc 32:2442–2447CrossRef de Lacy FB, van Laarhoven J, Pena R, Arroyave MC, Bravo R, Cuatrecasas M, Lacy AM (2018) Transanal total mesorectal excision: pathological results of 186 patients with mid and low rectal cancer. Surg Endosc 32:2442–2447CrossRef
12.
Zurück zum Zitat Koedam TWA, Veltcamp Helbach M, Penna M, Wijsmuller A, Doornebosch P, van Westreenen HL, Hompes R, Bonjer HJ, Sietses C, de Graaf E, Tuynman JB (2019) Short-term outcomes of transanal completion total mesorectal excision (cTaTME) for rectal cancer: a case-matched analysis. Surg Endosc 33:103–109CrossRef Koedam TWA, Veltcamp Helbach M, Penna M, Wijsmuller A, Doornebosch P, van Westreenen HL, Hompes R, Bonjer HJ, Sietses C, de Graaf E, Tuynman JB (2019) Short-term outcomes of transanal completion total mesorectal excision (cTaTME) for rectal cancer: a case-matched analysis. Surg Endosc 33:103–109CrossRef
13.
Zurück zum Zitat Veltcamp Helbach M, Koedam TWA, Knol JJ, Velthuis S, Bonjer HJ, Tuynman JB, Sietses C (2019) Quality of life after rectal cancer surgery: differences between laparoscopic and transanal total mesorectal excision. Surg Endosc 33:79–87CrossRef Veltcamp Helbach M, Koedam TWA, Knol JJ, Velthuis S, Bonjer HJ, Tuynman JB, Sietses C (2019) Quality of life after rectal cancer surgery: differences between laparoscopic and transanal total mesorectal excision. Surg Endosc 33:79–87CrossRef
14.
Zurück zum Zitat Kang S-B, Park JW, Jeong S-Y, Nam BH, Choi HS, Kim D-W, Lim S-B, Lee T-G, Kim DY, Kim J-S, Chang HJ, Lee H-S, Kim SY, Jung KH, Hong YS, Kim JH, Sohn DK, Kim D-H, Oh JH (2010) Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol 11:637–645CrossRef Kang S-B, Park JW, Jeong S-Y, Nam BH, Choi HS, Kim D-W, Lim S-B, Lee T-G, Kim DY, Kim J-S, Chang HJ, Lee H-S, Kim SY, Jung KH, Hong YS, Kim JH, Sohn DK, Kim D-H, Oh JH (2010) Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial. Lancet Oncol 11:637–645CrossRef
15.
Zurück zum Zitat Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17:1471–1474CrossRef Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17:1471–1474CrossRef
16.
Zurück zum Zitat Matsuda T, Sumi Y, Yamashita K, Hasegawa H, Yamamoto M, Matsuda Y, Kanaji S, Oshikiri T, Nakamura T, Suzuki S, Kakeji Y (2018) Outcomes and prognostic factors of selective lateral pelvic lymph node dissection with preoperative chemoradiotherapy for locally advanced rectal cancer. Int J Colorectal Dis 33:367–374CrossRef Matsuda T, Sumi Y, Yamashita K, Hasegawa H, Yamamoto M, Matsuda Y, Kanaji S, Oshikiri T, Nakamura T, Suzuki S, Kakeji Y (2018) Outcomes and prognostic factors of selective lateral pelvic lymph node dissection with preoperative chemoradiotherapy for locally advanced rectal cancer. Int J Colorectal Dis 33:367–374CrossRef
17.
Zurück zum Zitat Dickson EA, Penna M, Cunningham C, Ratcliffe FM, Chantler J, Crabtree NA, Tuynman JB, Albert MR, Monson JRT, Hompes R (2019) Carbon dioxide embolism associated with transanal total mesorectal excision surgery: a report from the international registries. Dis Colon Rectum 62:794–801CrossRef Dickson EA, Penna M, Cunningham C, Ratcliffe FM, Chantler J, Crabtree NA, Tuynman JB, Albert MR, Monson JRT, Hompes R (2019) Carbon dioxide embolism associated with transanal total mesorectal excision surgery: a report from the international registries. Dis Colon Rectum 62:794–801CrossRef
18.
Zurück zum Zitat Atallah S, DuBose A (2015) A mechanism for constructing a durable purse-string during transanal total mesorectal excision. Tech Coloproctol 19:751–752CrossRef Atallah S, DuBose A (2015) A mechanism for constructing a durable purse-string during transanal total mesorectal excision. Tech Coloproctol 19:751–752CrossRef
19.
Zurück zum Zitat Martin-Perez B, Otero-Pineiro A, Lacy AM (2018) Purse-string rupture: pitfalls of transanal total mesorectal excision (Cecil approach). Tech Coloproctol 22:393–394CrossRef Martin-Perez B, Otero-Pineiro A, Lacy AM (2018) Purse-string rupture: pitfalls of transanal total mesorectal excision (Cecil approach). Tech Coloproctol 22:393–394CrossRef
20.
Zurück zum Zitat Spinelli A, Carvello M, D'Hoore A, Foppa C (2019) Integration of transanal techniques for precise rectal transection and single-stapled anastomosis: a proof of concept study. Colorectal Dis 21:841–846CrossRef Spinelli A, Carvello M, D'Hoore A, Foppa C (2019) Integration of transanal techniques for precise rectal transection and single-stapled anastomosis: a proof of concept study. Colorectal Dis 21:841–846CrossRef
21.
Zurück zum Zitat Balaphas A, Dumont C, Faes S, Scarpa CR, Roche B, Ris F, Buchs NC, Hahnloser D (2018) Colonic conduit prolapse after transanal total mesorectal excision (taTME). Tech Coloproctol 22:475–477CrossRef Balaphas A, Dumont C, Faes S, Scarpa CR, Roche B, Ris F, Buchs NC, Hahnloser D (2018) Colonic conduit prolapse after transanal total mesorectal excision (taTME). Tech Coloproctol 22:475–477CrossRef
22.
Zurück zum Zitat Gys B, Patteet E, Van den Broeck S, Hubens G, Komen N (2018) Robotic posterior suturepexy for colonic prolapse two years after transanal total mesorectal excision for low rectal cancer. Dis Colon Rectum 61:1454CrossRef Gys B, Patteet E, Van den Broeck S, Hubens G, Komen N (2018) Robotic posterior suturepexy for colonic prolapse two years after transanal total mesorectal excision for low rectal cancer. Dis Colon Rectum 61:1454CrossRef
23.
Zurück zum Zitat Wasmuth HH, Faerden AE, Myklebust TÅ, Pfeffer F, Norderval S, Riis R, Olsen OC, Lambrecht JR, Kørner H, Larsen SG, Norwegian TaTME Collaborative Group, on behalf of the Norwegian Colorectal Cancer Group, Forsmo HM, Baekkelund O, Lavik S, Knapp JC, Sjo O, Rashid G (2020) Transanal total mesorectal excision for rectal cancer has been suspended in Norway. Br J Surg 107(1):121–130CrossRef Wasmuth HH, Faerden AE, Myklebust TÅ, Pfeffer F, Norderval S, Riis R, Olsen OC, Lambrecht JR, Kørner H, Larsen SG, Norwegian TaTME Collaborative Group, on behalf of the Norwegian Colorectal Cancer Group, Forsmo HM, Baekkelund O, Lavik S, Knapp JC, Sjo O, Rashid G (2020) Transanal total mesorectal excision for rectal cancer has been suspended in Norway. Br J Surg 107(1):121–130CrossRef
24.
Zurück zum Zitat Japanese Society for Cancer of the Colon and Rectum (2019) Japanese classification of colorectal, appendiceal, and anal carcinoma, Thrid English edn. Kanehara, Tokyo Japanese Society for Cancer of the Colon and Rectum (2019) Japanese classification of colorectal, appendiceal, and anal carcinoma, Thrid English edn. Kanehara, Tokyo
Metadaten
Titel
Clinical outcomes of transanal total mesorectal excision using a lateral-first approach for low rectal cancer: a propensity score matching analysis
verfasst von
Takeru Matsuda
Kimihiro Yamashita
Hiroshi Hasegawa
Masataka Fujikawa
Hiroki Sakamoto
Masashi Yamamoto
Shingo Kanaji
Taro Oshikiri
Tetsu Nakamura
Satoshi Suzuki
Yoshihiro Kakeji
Publikationsdatum
23.09.2020
Verlag
Springer US
Erschienen in
Surgical Endoscopy / Ausgabe 2/2021
Print ISSN: 0930-2794
Elektronische ISSN: 1432-2218
DOI
https://doi.org/10.1007/s00464-020-08024-2

Weitere Artikel der Ausgabe 2/2021

Surgical Endoscopy 2/2021 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.